Joost L. Boormans
Erasmus MC Cancer Institute(NL)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation
Most-Cited Works
- → Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy(2017)780 cited
- → Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study(2021)516 cited
- → European Association of Urology Guidelines on Testicular Cancer: 2023 Update(2023)211 cited
- → EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†(2019)190 cited
- → EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees(2019)180 cited
- → Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer(2020)176 cited
- → Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy(2016)150 cited
- → Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel(2017)125 cited
- → Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”(2020)124 cited
- → Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer(2018)123 cited